Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Designates 17th Notified Body Under MDR

Executive Summary

Despite COVID-19 distancing measures and fears that new notified body appointments would grind to a halt, there is now a new notified body for the EU Medical Device Regulation.

You may also be interested in...



First MDR Notified Body Designated In Finland As Nordic Numbers Nudge Up

The latest update in the Medical Device Regulation page of the European Commission's Nando database represents the 18th listing under the new regulation. Numbers are rising slowly.

Designation Of EU Notified Bodies: Is There Evidence Of Bias?

With the EU having now announced 20 notified body designations against the EU’s Medical Device and IVD Regulations, some clear patterns have emerged. But the Commission denies any bias.

European Commission Appoints 12th MDR Notified Body

Despite industry’s urgent need to have their products assessed by notified bodies under the MDR, appointments are coming through slowly.

Topics

UsernamePublicRestriction

Register

OM005224

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel